Profile

Antiverse

Antiverse is building a world-first computational antibody drug discovery platform. They combine in-house lab expertise with state of the art machine learning to predict antibody-antigen binding and provide antibody drug candidates in one day.

Status current

Associated Fund UK Innovation & Science Seed Fund

Sector Medical / Biotechnology

Website www.antiverse.io/

Associated Team Members

Blog

Planning for reopening – how to accelerate out of lockdown

The government’s roadmap out of the lockdown is currently going to plan and we...

read more

How can your businesses ensure resilience?

There is no doubt that the past 12 months has seen the majority of...

read more

More Companies in Medical / Biotechnology

Your browser is out-of-date!

Update your browser to view this website correctly.Update my browser now

×